Results for “”

Entry Author Date Location
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash 06/26/20 National
Eye Inflammation Dooms AbbVie Wet AMD Drug to an FDA Rejection 06/26/20 National
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis 06/24/20 National
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Timing Is an Essential Element of Cell & Gene Therapy Product Development 06/19/20 Philadelphia
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Pharma Partnering: Perspectives from Xcelerating Life Sciences Panel 06/16/20 Philadelphia
Jazz Pharma Gets Quick FDA OK for New Small Cell Lung Cancer Drug 06/15/20 National
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Cytovia Therapeutics Adds OliX’s Wei Li as Chief Scientific Officer 06/03/20 New York
Aruvant Taps Sarepta’s Palaniappan as Chief Technology Officer 06/03/20 New York
Page 1 of 309 next page »